Fleig Susanne V, Konen Franz F, Schröder Christoph, Schmitz Jessica, Gingele Stefan, Bräsen Jan H, Lovric Svjetlana, Schmidt Bernhard M W, Haller Hermann, Skripuletz Thomas, von Vietinghoff Sibylle
Department of Internal Medicine, Division of Nephrology and Hypertension, Hannover Medical School, Hannover.
Nephrology Section, Medical Clinic 1, University Hospital Bonn, Rheinische Friedrich-Wilhelms University, Bonn, Germany.
Immun Inflamm Dis. 2021 Dec;9(4):1479-1488. doi: 10.1002/iid3.499. Epub 2021 Jul 29.
Chronic kidney disease (CKD) is a common condition that increases mortality and the risk of cardiovascular and other morbidities regardless of underlying renal condition. Chronic inflammation promotes renal fibrosis. Recently, renal B cell infiltrates were described in chronic kidney disease of various etiologies beyond autoimmunity.
We here investigated B cells and indicators of tertiary lymphoid structure formation in human renal biopsies. Renal function was studied during long-term B cell depletion in human patients with membranous nephropathy and with CKD of unknown origin.
Cytokine profiles of tertiary lymphoid structure formation were detected in human renal interstitium in a range of kidney diseases. Complex B cell structures consistent with tertiary lymphoid organ formation were evident in human membranous nephropathy. Here, B cell density did not significantly associate with proteinuria severity, but with worse excretory renal function. Proteinuria responses mostly occurred within the first 6 months of B cell depletion. In contrast, recovery of excretory kidney function was observed only after 18 months of continuous therapy, consistent with a structural process. Renal tertiary lymphatic structures were also detected in the absence of autoimmune kidney disease. To start to address whether B cell depletion may affect CKD in a broader population, we assessed kidney function in neurologic patients with CKD of unknown origin. In this cohort, eGFR significantly increased within 24 months of B cell depletion.
Long-term B cell depletion associated with significant improvement of excretory kidney function in human CKD. Kinetics and mechanisms of renal B cell aggregation should be investigated further to stratify the impact of B cells and their aggregates as therapeutic targets.
慢性肾脏病(CKD)是一种常见疾病,无论潜在的肾脏状况如何,都会增加死亡率以及心血管疾病和其他疾病的发病风险。慢性炎症会促进肾纤维化。最近,在各种病因的慢性肾脏病中,除自身免疫性疾病外,还发现了肾脏B细胞浸润。
我们在此研究了人类肾活检组织中的B细胞和三级淋巴结构形成指标。在患有膜性肾病和不明原因CKD的人类患者长期B细胞耗竭期间,对肾功能进行了研究。
在一系列肾脏疾病的人类肾间质中检测到了三级淋巴结构形成的细胞因子谱。在人类膜性肾病中,与三级淋巴器官形成一致的复杂B细胞结构很明显。在此,B细胞密度与蛋白尿严重程度无显著相关性,但与排泄肾功能较差有关。蛋白尿反应大多发生在B细胞耗竭的前6个月内。相比之下,仅在持续治疗18个月后才观察到排泄肾功能的恢复,这与一个结构过程一致。在没有自身免疫性肾脏疾病的情况下也检测到了肾脏三级淋巴结构。为了开始探讨B细胞耗竭是否可能在更广泛的人群中影响CKD,我们评估了患有不明原因CKD的神经系统疾病患者的肾功能。在这个队列中,B细胞耗竭24个月内估算肾小球滤过率(eGFR)显著增加。
长期B细胞耗竭与人类CKD患者排泄肾功能的显著改善相关。应进一步研究肾脏B细胞聚集的动力学和机制,以分层分析B细胞及其聚集物作为治疗靶点的影响。